The main aim of Dokuz Eylül National Health Industries Association (DENHIA), which was established to cooperate and collaborate with a wide range of stakeholders creating values in all areas of health, from pharmaceutical companies to biotechnology initiatives, from telemedicine applications to genetic research, from medical devices to wearable technologies, is to break new ground by producing innovative products and prototypes with the companies within its body, by leveraging the research power within the Research and Application Hospital, including clinical studies centre.
DUSED, with its associated partners of Dokuz Eylül University which is one of the research universities in our country, Izmir Biomedicine and Genome Center (IBGC), and BioIzmir as the health accelerator centre has the power to host all clinical studies in Research and Application Hospital. Its research and development activities are carried out significantly with the internal academic staff of the university by bringing new products to pilot production stage within BioIzmir.
DUSED also provides access to national and international markets, and the transformation of national technologies developed within DEPARK and Dokuz Eylül University Technology Transfer Office (DETTO) into commercialized technological products and services.
DENHIA which was established by the only health industry development zone in Turkiye has all these processes under its dominance, opens its doors to all sector representatives on the way to become national and international brands.
GRAPHENEXPRESS İleri Malzeme Teknolojileri Dan. San. ve Tic. LTD. ŞTİ.
ORGANO-ID Biyoteknoloji Laboratuvar Hiz. San. ve Tic. A.Ş.
RM Tekstil A.Ş.
Yıldız Tıp Sağlık Ürünleri Endüstriyel Maddeler San. ve Tic. LTD. ŞTİ.